Interestingly, the detrimental prognosis caused by VSIG4 expression may also be mitigated by the high levels of CD8+ TILs, indicating that VSIG4 could worsen DLBCL prognosis through mechanisms independent of CD8+ TIL regulation. Here, CD8A is linked to diffuse large B-cell lymphoma.